L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AB Alkyl sulfonates
L01AC Ethylene imines
L01AD Nitrosoureas
L01AG Epoxides
L01AX Other alkylating agents
L01B ANTIMETABOLITES
L01BA Folic acid analogues
L01BB Purine analogues
L01BC Pyrimidine analogues
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CA Vinca alkaloids and analogues
L01CB Podophyllotoxin derivatives
L01CC Colchicine derivatives
L01CD Taxanes
L01CE Topoisomerase 1 (TOP1) inhibitors
L01CX Other plant alkaloids and natural products
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
L01DA Actinomycines
L01DB Anthracyclines and related substances
L01DC Other cytotoxic antibiotics
L01E PROTEIN KINASE INHIBITORS
L01EA BCR-ABL tyrosine kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
L01ED Anaplastic lymphoma kinase (ALK) inhibitors
L01EE Mitogen-activated protein kinase (MEK) inhibitors
L01EF Cyclin-dependent kinase (CDK) inhibitors
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EJ Janus-associated kinase (JAK) inhibitors
L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
L01EL Bruton's tyrosine kinase (BTK) inhibitors
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
L01EX Other protein kinase inhibitors
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FA CD20 (Clusters of Differentiation 20) inhibitors
L01FB CD22 (Clusters of Differentiation 22) inhibitors
L01FC CD38 (Clusters of Differentiation 38) inhibitors
L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors
L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
L01FX Other monoclonal antibodies and antibody drug conjugates
L01X OTHER ANTINEOPLASTIC AGENTS
L01XA Platinum compounds
L01XB Methylhydrazines
L01XD Sensitizers used in photodynamic/radiation therapy
L01XF Retinoids for cancer treatment
L01XG Proteasome inhibitors
L01XH Histone deacetylase (HDAC) inhibitors
L01XJ Hedgehog pathway inhibitors
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
L01XX Other antineoplastic agents
L01XY Combinations of antineoplastic agents

L02 ENDOCRINE THERAPY
L02A HORMONES AND RELATED AGENTS
L02AA Estrogens
L02AB Progestogens
L02AE Gonadotropin releasing hormone analogues
L02AX Other hormones
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BA Anti-estrogens
L02BB Anti-androgens
L02BG Aromatase inhibitors
L02BX Other hormone antagonists and related agents

L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AA Colony stimulating factors
L03AB Interferons
L03AC Interleukins
L03AX Other immunostimulants

L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AA Selective immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-Î±) inhibitors
L04AC Interleukin inhibitors
L04AD Calcineurin inhibitors
L04AX Other immunosuppressants